Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06743295 · ClinicalTrials.gov registry record · NA

AI Noise Reduction in Phonak Hearing Aids

A NA study of Hearing Loss, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06743295 is a NA study of Hearing Loss that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 500 participants, below the 6,112-participant average among 58 other Hearing Loss trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06743295, a NA study of Hearing Loss, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

Conditions Studied

Interventions

  • DEVICE DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-04-24
Est. Completion 2027-01-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06743295

The ClinicalTrials.gov registry entry for NCT06743295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,112-participant average among 58 other Hearing Loss trials with a reported enrollment target (92% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction is the first listed.

NCT06743295 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06743295 about?

NCT06743295 is a clinical study titled "AI Noise Reduction in Phonak Hearing Aids". The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

What is the current status of trial NCT06743295?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-24. Estimated completion is 2027-01-01.

What conditions does trial NCT06743295 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT06743295?

The interventions under investigation include: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction (DEVICE).

Who is sponsoring clinical trial NCT06743295?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06743295 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.